Corlieve Therapeutics - Ownership and Business Overview

Life ScienceCompany

Corlieve Therapeutics Ownership

Who owns Corlieve Therapeutics?

Corlieve Therapeutics is owned by uniQure N.V.. It was acquired on June 22, 2021.

Corlieve Therapeutics Business Overview

Where is Corlieve Therapeutics headquartered?

Corlieve Therapeutics is headquartered in Paris, France.

What sector is Corlieve Therapeutics in?

Corlieve Therapeutics is a life science company.

When was Corlieve Therapeutics founded?

Corlieve Therapeutics was founded in 2019.

Life Science M&A Summary in 2021

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2021. The largest life science acquisition in 2021 was Pharmaceutical Product Development - which was acquired by Thermo Fisher Scientific for $17.4B.

Join Mergr to view all 392 acquisitions of life science companies in 2021, including 46 acquisitions by private equity firms, and 346 by strategics.

Corlieve Therapeutics

Corlieve Therapeutics SAS

59 Rue de Ponthieu,
Paris, 75008
France,
www.corlieve.com

Corlieve Therapeutics is a biotechnology company focused on bringing novel therapeutic options to patients with severe neurological disorders. The lead project is targeting aberrantly expressed kainate receptors in the hippocampus of patients with refractory TLE using a gene therapy approach. Corlieve was founded by Kurma Partners 4Q2019 on the basis of a partnership with REGENXBIO Inc., SATT Aquitaine Science Transfert, and Inserm Transfert. Corlieve Therapeutics was founded in 2019 is based in Paris, France.


 Subscribe to unlock this and 207,390
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Corlieve Therapeutics

Life Science Companies , France Companies